D-0556-2024 Class III Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

FDA drug recall D-0556-2024 was initiated by Eugia US LLC on May 22, 2024 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer. The recall status is ongoing. Affected quantity: 15,500 single dose vials.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2024
Initiation Date
May 22, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,500 single dose vials

Product description

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

Reason for recall

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Distribution pattern

USA nationwide.

Code information

Lot #: 3EF22003, Exp 6/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0556-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0556-2024. Report a data issue: hello@regdatalab.com.